Avenue Therapeutics, Inc. Profile Avatar - Palmy Investing

Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in…

Biotechnology
US, New York [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of ATXI's Analysis
CIK: 1644963 CUSIP: 05360L205 ISIN: US05360L3042 LEI: - UEI: -
Secondary Listings
ATXI has no secondary listings inside our databases.